pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 7·1 min read
save

Digital health firms eye CMS ACCESS Medicare pilot despite modest reimbursement

Jul 7, 2026·read at Endpoints ↗RegulatoryNeutral

A new Medicare initiative called CMS ACCESS is being launched to manage chronic diseases among seniors.

The program will contract digital health companies to provide remote monitoring and other services, but the reimbursement rates are low, roughly equivalent to the revenue from a few patient visits with commercial insurers.

Analysts note that while the pilot offers a pathway for digital health firms to enter the Medicare market, the modest payments may limit the financial incentive for many companies.

The experiment could shape how digital health tools are integrated into senior care, and stakeholders will watch the outcomes to assess scalability and sustainability.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “How digital health companies are planning to conquer CMS ACCESS”

read at Endpoints ↗
86 words · retrieved Jul 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 9h agoThe race to make new Ebola vaccines faces a cash crunchEndpoints
  • 10h agoUS-China biotech NeuShen gets $80M to develop brain-health drugsEndpoints
  • 10h agoIonis wins FDA approval of Alexander disease drug zilganersenEndpoints
  • 13h agoThiel-backed Lindus sells CRO arm in pivot to hunt for drug assetsEndpoints
  • 14h agoItaly's Menarini gets into obesity with European rights to GLP-1 from China's Gan & LeeEndpoints